Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases

Journal of the Neurological Sciences

Volumn 136, Issue 1-2, 1996, Pages 162-168

  Ahlskog, J Eric ^a   Uitti, Ryan J ^b   Tyce, Gertrude M ^a   O'Brien, John F ^a   Petersen, Ronald C ^a   Kokmen, Emre ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Catecholamine; DOPAC; DOPEG; Monoamine oxidase; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DIHYDROXYPHENYLACETIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CATECHOLAMINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0029990149     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00318-V     Document Type: Article

References (24)

1. Adolfsson, R. et al. (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci., 27: 1029-1034.
2. Ahlskog, J.E. et al. (1996) Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology, in press.
3. Averback, P. (1983) Two new lesions in Alzheimer's disease. Lancet ii: 1203.
4. Bagdy, G. and Z. Rihmer (1986) Measurement of platelet monoamine oxidase activity in healthy human volunteers. Acta Physiol. Hung. 68:19-24.
5. Bonuccelli, U. et al. (1990) Platelet monoamine oxidase B activity in parkinsonian patients. J. Neurol. Neurosurg. Psychiatry, 53: 854-855.
6. Cedarbaum, J.M. et al. (1990) L-Deprenyl, levodopa pharmacokinetics, and response fluctuations in Parkinson's disease. Clin. Neuropharma-col., 13: 29-35.
7. Cervera, P. et al. (1988) Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients. J. Neurol. Neurosurg. Psychiatry, 51: 1104-1105.
8. Checkoway, H. et al. (1992) Peripheral blood cell activities of monoamine oxidase B and Superoxide dismutase in Parkinson's disease. J. Neural. Transm. Park Dis. Dement Sect. 4: 283-290.
9. Danielczyk, W. et al. (1988) Platelet MAO-B activity and the psy-chopathology of Parkinson's disease, senile dementia and multi-in-farct dementia. Acta Psychiatr. Scand. 78: 730-736.
10. den Hartog Jager, W.A. (1970) Histochemistry of adrenal bodies in Parkinson's disease. Arch. Neurol. 23: 528-233.
11. den Hartog Jager, W.A. and J. Bethlem (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J. Neurol. Neurosurg. Psychiatry, 23: 283-290.
12. Devalon, M.L. et al. (1989) Dopa in plasma increases during acute exercise and after exercise training." J. Lab. Clin. Med., 114: 321-327.
13. Durrieu, G. et al. (1990) Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective Dl agonist (CY 208-243). Neurology, 40: 707-709.
14. Friedman, E. et al. (1974) Blood platelet monoamine oxidase activity in psychiatric patients. Am. J. Psychiatry 131: 1392-1394.
15. Glover, V. et al. (1983) Platelet phenolsulphotransferase activity in Parkinson's disease. J. Neural. Transm., 57: 95-102.
16. Goldstein, D.S. et al. (1987) Neuronal source of plasma dihydroxypheny-lalanine. J. Clin. Endocrinol. Metab., 64: 856-861.
17. Hartman, M.G. et al. (1988) Catecholamine levels are reduced in the adrenal medulla of Parkinson patients receiving autologous transplantation. Soc. Neurosci. Abstr., 14: 8.
18. Hoeldtke, R. et al. (1972) Dihydroxyphenylalanine in rat food containing wheat and oats. Science, 175: 761-762.
19. Hotamisligil, G.S. et al. (1994) Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov. Disord., 9:305-310.
20. Hovevey-Sion, D. et al. (1989) Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology, 28: 791-797.
21. Humfrey C.D. et al. (1990) Monoamine oxidase substrates in Parkinson's disease. Biochem. Pharmacol., 40: 2562-2564.
22. Hunter, L.W., et al. (1988) Concurrent separation of catecholamines, dihydroxyphenylglycol, vasoactive intestinal peptide and neuropeptide Y in superfusate and tissue extract. Anal. Biochem., 173: 340-352.
23. Jarman, J. et al. (1993) Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation. J. Neural. Transm. Park. Dis. Dement. Sect. 5: 1-4.
24. Kimula, Y. et al. (1983) Element analysis of Lewy and adrenal bodies in Parkinson's disease by electron probe microanalysis. Acta Neuropathol. (Berl.), 59: 233-236.